Literature DB >> 18386469

Risk factors for cervical cancer in China: a case-control study.

H B Cai1, X H Ding, Y F Zhou, D M Lie.   

Abstract

OBJECTIVES: To determine the prevalence of human papillomavirus types and investigate the risk factors for cervical cancer in Hubei, China.
METHODS: We conducted a case-control study to investigate risk factors.
RESULTS: HPV DNA was detected in 94.55% of patients with cervical carcinoma, and 23.64% of control subjects. The most common HPV type in cervical cancer was HPV type 16 (81.82%), followed by HPV 58 (6.36%). HPV infected patients have a higher risk of developing cervical carcinoma, which is 75.79 times more than non-infected people. The other risks were age at first intercourse (p = 0.017) and number of live births (p = 0.032). A history of previous cytologic screening was associated with a substantial reduction in risk (p = 0.001).
CONCLUSIONS: The three principal reasons that Hubei has a high rate of women developing cervical carcinoma are HPV infection, age at first sexual intercourse and number of live births. Cervical cytology screening provides efficacious protection.

Entities:  

Mesh:

Year:  2008        PMID: 18386469

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  4 in total

1.  Incidence and mortality trend of cervical cancer in 11 cancer registries of china.

Authors:  Tao Lei; Wei-Min Mao; Tong-Hai Lei; Li-Qiong Dai; Luo Fang; Wan-Qing Chen; Si-Wei Zhang
Journal:  Chin J Cancer Res       Date:  2011-03       Impact factor: 5.087

2.  Safety and immunogenicity of human papillomavirus-16/18 AS04-adjuvanted vaccine in healthy Chinese females aged 15 to 45 years: a phase I trial.

Authors:  Feng-Cai Zhu; Chang-Gui Li; Hong-Xing Pan; Yi-Ju Zhang; Dan Bi; Hai-Wen Tang; Sanjoy Datta
Journal:  Chin J Cancer       Date:  2011-08

3.  Multi-Habitat Based Radiomics for the Prediction of Treatment Response to Concurrent Chemotherapy and Radiation Therapy in Locally Advanced Cervical Cancer.

Authors:  Mengjie Fang; Yangyang Kan; Di Dong; Tao Yu; Nannan Zhao; Wenyan Jiang; Lianzhen Zhong; Chaoen Hu; Yahong Luo; Jie Tian
Journal:  Front Oncol       Date:  2020-05-05       Impact factor: 6.244

4.  High parity is associated with increased risk of cervical cancer: Systematic review and meta-analysis of case-control studies.

Authors:  Yohannes Tekalegn; Biniyam Sahiledengle; Demelash Woldeyohannes; Daniel Atlaw; Sisay Degno; Fikreab Desta; Kebebe Bekele; Tesfaye Aseffa; Habtamu Gezahegn; Chala Kene
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.